Mankind Pharma IPO sails through on Day 3
Around nine brokerages have given "subscribe" recommendations on the issue, with some of them seeing the potential in the long term. Analysts say the growth opportunities outweigh the concerns around not so cheap valuations.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
